Radiopharmaceuticals (also known as radioactive drugs) are drugs that contain radionuclides that emit radiation. The distribution of the radiopharmaceutical within the body is determined by the physiochemical properties of the drug, the stability of the radiolabel, the purity of the radiopharmaceutical preparation, the pathophysiologic state of the patient, and the presence or absence of interfering drugs. Dynamic and static images of the distribution of the radiopharmaceutical within the body can be obtained using a g-camera or another suitable instrument appropriate for the radiopharmaceutical being imagedfor example, positronemitting radiopharmaceuticals.
This report contains market size and forecasts of Nuclear Medicine & Radiopharmaceuticals in global, including the following market information:
Global Nuclear Medicine & Radiopharmaceuticals Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Nuclear Medicine & Radiopharmaceuticals Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Nuclear Medicine & Radiopharmaceuticals companies in 2021 (%)
The global Nuclear Medicine & Radiopharmaceuticals market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Diagnostic Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Nuclear Medicine & Radiopharmaceuticals include China Isotope & Radiation, Dongcheng, Jaco, Ciaeriar, Advanced Molecular-imaging Solution and Shanghai Atom Kexing, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Nuclear Medicine & Radiopharmaceuticals manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Nuclear Medicine & Radiopharmaceuticals Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Nuclear Medicine & Radiopharmaceuticals Market Segment Percentages, by Type, 2021 (%)
- Diagnostic
- Therapeutic
Global Nuclear Medicine & Radiopharmaceuticals Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Nuclear Medicine & Radiopharmaceuticals Market Segment Percentages, by Application, 2021 (%)
- Oncology
- Thyroid
- Cardiology
- Others
Global Nuclear Medicine & Radiopharmaceuticals Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Nuclear Medicine & Radiopharmaceuticals Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- - US
- - Canada
- - Mexico
- Europe
- - Germany
- - France
- - U.K.
- - Italy
- - Russia
- - Nordic Countries
- - Benelux
- - Rest of Europe
- Asia
- - China
- - Japan
- - South Korea
- - Southeast Asia
- - India
- - Rest of Asia
- South America
- - Brazil
- - Argentina
- - Rest of South America
- Middle East & Africa
- - Turkey
- - Israel
- - Saudi Arabia
- - UAE
- - Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Nuclear Medicine & Radiopharmaceuticals revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Nuclear Medicine & Radiopharmaceuticals revenues share in global market, 2021 (%)
Key companies Nuclear Medicine & Radiopharmaceuticals sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Nuclear Medicine & Radiopharmaceuticals sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- China Isotope & Radiation
- Dongcheng
- Jaco
- Ciaeriar
- Advanced Molecular-imaging Solution
- Shanghai Atom Kexing
Nuclear Medicine & Radiopharmaceuticals Market - Global Outlook and Forecast 2022-2028
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Nuclear Medicine & Radiopharmaceuticals Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Nuclear Medicine & Radiopharmaceuticals Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Nuclear Medicine & Radiopharmaceuticals Overall Market Size
2.1 Global Nuclear Medicine & Radiopharmaceuticals Market Size: 2021 VS 2028
2.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Nuclear Medicine & Radiopharmaceuticals Sales: 2017-2028
3 Company Landscape
3.1 Top Nuclear Medicine & Radiopharmaceuticals Players in Global Market
3.2 Top Global Nuclear Medicine & Radiopharmaceuticals Companies Ranked by Revenue
3.3 Global Nuclear Medicine & Radiopharmaceuticals Revenue by Companies
3.4 Global Nuclear Medicine & Radiopharmaceuticals Sales by Companies
3.5 Global Nuclear Medicine & Radiopharmaceuticals Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Nuclear Medicine & Radiopharmaceuticals Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Nuclear Medicine & Radiopharmaceuticals Product Type
3.8 Tier 1, Tier 2 and Tier 3 Nuclear Medicine & Radiopharmaceuticals Players in Global Market
3.8.1 List of Global Tier 1 Nuclear Medicine & Radiopharmaceuticals Companies
3.8.2 List of Global Tier 2 and Tier 3 Nuclear Medicine & Radiopharmaceuticals Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Nuclear Medicine & Radiopharmaceuticals Market Size Markets, 2021 & 2028
4.1.2 Diagnostic
4.1.3 Therapeutic
4.2 By Type - Global Nuclear Medicine & Radiopharmaceuticals Revenue & Forecasts
4.2.1 By Type - Global Nuclear Medicine & Radiopharmaceuticals Revenue, 2017-2022
4.2.2 By Type - Global Nuclear Medicine & Radiopharmaceuticals Revenue, 2023-2028
4.2.3 By Type - Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share, 2017-2028
4.3 By Type - Global Nuclear Medicine & Radiopharmaceuticals Sales & Forecasts
4.3.1 By Type - Global Nuclear Medicine & Radiopharmaceuticals Sales, 2017-2022
4.3.2 By Type - Global Nuclear Medicine & Radiopharmaceuticals Sales, 2023-2028
4.3.3 By Type - Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share, 2017-2028
4.4 By Type - Global Nuclear Medicine & Radiopharmaceuticals Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Nuclear Medicine & Radiopharmaceuticals Market Size, 2021 & 2028
5.1.2 Oncology
5.1.3 Thyroid
5.1.4 Cardiology
5.1.5 Others
5.2 By Application - Global Nuclear Medicine & Radiopharmaceuticals Revenue & Forecasts
5.2.1 By Application - Global Nuclear Medicine & Radiopharmaceuticals Revenue, 2017-2022
5.2.2 By Application - Global Nuclear Medicine & Radiopharmaceuticals Revenue, 2023-2028
5.2.3 By Application - Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share, 2017-2028
5.3 By Application - Global Nuclear Medicine & Radiopharmaceuticals Sales & Forecasts
5.3.1 By Application - Global Nuclear Medicine & Radiopharmaceuticals Sales, 2017-2022
5.3.2 By Application - Global Nuclear Medicine & Radiopharmaceuticals Sales, 2023-2028
5.3.3 By Application - Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share, 2017-2028
5.4 By Application - Global Nuclear Medicine & Radiopharmaceuticals Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Nuclear Medicine & Radiopharmaceuticals Market Size, 2021 & 2028
6.2 By Region - Global Nuclear Medicine & Radiopharmaceuticals Revenue & Forecasts
6.2.1 By Region - Global Nuclear Medicine & Radiopharmaceuticals Revenue, 2017-2022
6.2.2 By Region - Global Nuclear Medicine & Radiopharmaceuticals Revenue, 2023-2028
6.2.3 By Region - Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share, 2017-2028
6.3 By Region - Global Nuclear Medicine & Radiopharmaceuticals Sales & Forecasts
6.3.1 By Region - Global Nuclear Medicine & Radiopharmaceuticals Sales, 2017-2022
6.3.2 By Region - Global Nuclear Medicine & Radiopharmaceuticals Sales, 2023-2028
6.3.3 By Region - Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Nuclear Medicine & Radiopharmaceuticals Revenue, 2017-2028
6.4.2 By Country - North America Nuclear Medicine & Radiopharmaceuticals Sales, 2017-2028
6.4.3 US Nuclear Medicine & Radiopharmaceuticals Market Size, 2017-2028
6.4.4 Canada Nuclear Medicine & Radiopharmaceuticals Market Size, 2017-2028
6.4.5 Mexico Nuclear Medicine & Radiopharmaceuticals Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Nuclear Medicine & Radiopharmaceuticals Revenue, 2017-2028
6.5.2 By Country - Europe Nuclear Medicine & Radiopharmaceuticals Sales, 2017-2028
6.5.3 Germany Nuclear Medicine & Radiopharmaceuticals Market Size, 2017-2028
6.5.4 France Nuclear Medicine & Radiopharmaceuticals Market Size, 2017-2028
6.5.5 U.K. Nuclear Medicine & Radiopharmaceuticals Market Size, 2017-2028
6.5.6 Italy Nuclear Medicine & Radiopharmaceuticals Market Size, 2017-2028
6.5.7 Russia Nuclear Medicine & Radiopharmaceuticals Market Size, 2017-2028
6.5.8 Nordic Countries Nuclear Medicine & Radiopharmaceuticals Market Size, 2017-2028
6.5.9 Benelux Nuclear Medicine & Radiopharmaceuticals Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Nuclear Medicine & Radiopharmaceuticals Revenue, 2017-2028
6.6.2 By Region - Asia Nuclear Medicine & Radiopharmaceuticals Sales, 2017-2028
6.6.3 China Nuclear Medicine & Radiopharmaceuticals Market Size, 2017-2028
6.6.4 Japan Nuclear Medicine & Radiopharmaceuticals Market Size, 2017-2028
6.6.5 South Korea Nuclear Medicine & Radiopharmaceuticals Market Size, 2017-2028
6.6.6 Southeast Asia Nuclear Medicine & Radiopharmaceuticals Market Size, 2017-2028
6.6.7 India Nuclear Medicine & Radiopharmaceuticals Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Nuclear Medicine & Radiopharmaceuticals Revenue, 2017-2028
6.7.2 By Country - South America Nuclear Medicine & Radiopharmaceuticals Sales, 2017-2028
6.7.3 Brazil Nuclear Medicine & Radiopharmaceuticals Market Size, 2017-2028
6.7.4 Argentina Nuclear Medicine & Radiopharmaceuticals Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales, 2017-2028
6.8.3 Turkey Nuclear Medicine & Radiopharmaceuticals Market Size, 2017-2028
6.8.4 Israel Nuclear Medicine & Radiopharmaceuticals Market Size, 2017-2028
6.8.5 Saudi Arabia Nuclear Medicine & Radiopharmaceuticals Market Size, 2017-2028
6.8.6 UAE Nuclear Medicine & Radiopharmaceuticals Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 China Isotope & Radiation
7.1.1 China Isotope & Radiation Corporate Summary
7.1.2 China Isotope & Radiation Business Overview
7.1.3 China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Major Product Offerings
7.1.4 China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Sales and Revenue in Global (2017-2022)
7.1.5 China Isotope & Radiation Key News
7.2 Dongcheng
7.2.1 Dongcheng Corporate Summary
7.2.2 Dongcheng Business Overview
7.2.3 Dongcheng Nuclear Medicine & Radiopharmaceuticals Major Product Offerings
7.2.4 Dongcheng Nuclear Medicine & Radiopharmaceuticals Sales and Revenue in Global (2017-2022)
7.2.5 Dongcheng Key News
7.3 Jaco
7.3.1 Jaco Corporate Summary
7.3.2 Jaco Business Overview
7.3.3 Jaco Nuclear Medicine & Radiopharmaceuticals Major Product Offerings
7.3.4 Jaco Nuclear Medicine & Radiopharmaceuticals Sales and Revenue in Global (2017-2022)
7.3.5 Jaco Key News
7.4 Ciaeriar
7.4.1 Ciaeriar Corporate Summary
7.4.2 Ciaeriar Business Overview
7.4.3 Ciaeriar Nuclear Medicine & Radiopharmaceuticals Major Product Offerings
7.4.4 Ciaeriar Nuclear Medicine & Radiopharmaceuticals Sales and Revenue in Global (2017-2022)
7.4.5 Ciaeriar Key News
7.5 Advanced Molecular-imaging Solution
7.5.1 Advanced Molecular-imaging Solution Corporate Summary
7.5.2 Advanced Molecular-imaging Solution Business Overview
7.5.3 Advanced Molecular-imaging Solution Nuclear Medicine & Radiopharmaceuticals Major Product Offerings
7.5.4 Advanced Molecular-imaging Solution Nuclear Medicine & Radiopharmaceuticals Sales and Revenue in Global (2017-2022)
7.5.5 Advanced Molecular-imaging Solution Key News
7.6 Shanghai Atom Kexing
7.6.1 Shanghai Atom Kexing Corporate Summary
7.6.2 Shanghai Atom Kexing Business Overview
7.6.3 Shanghai Atom Kexing Nuclear Medicine & Radiopharmaceuticals Major Product Offerings
7.6.4 Shanghai Atom Kexing Nuclear Medicine & Radiopharmaceuticals Sales and Revenue in Global (2017-2022)
7.6.5 Shanghai Atom Kexing Key News
8 Global Nuclear Medicine & Radiopharmaceuticals Production Capacity, Analysis
8.1 Global Nuclear Medicine & Radiopharmaceuticals Production Capacity, 2017-2028
8.2 Nuclear Medicine & Radiopharmaceuticals Production Capacity of Key Manufacturers in Global Market
8.3 Global Nuclear Medicine & Radiopharmaceuticals Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Nuclear Medicine & Radiopharmaceuticals Supply Chain Analysis
10.1 Nuclear Medicine & Radiopharmaceuticals Industry Value Chain
10.2 Nuclear Medicine & Radiopharmaceuticals Upstream Market
10.3 Nuclear Medicine & Radiopharmaceuticals Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Nuclear Medicine & Radiopharmaceuticals Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Nuclear Medicine & Radiopharmaceuticals in Global Market
Table 2. Top Nuclear Medicine & Radiopharmaceuticals Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Nuclear Medicine & Radiopharmaceuticals Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Nuclear Medicine & Radiopharmaceuticals Revenue Share by Companies, 2017-2022
Table 5. Global Nuclear Medicine & Radiopharmaceuticals Sales by Companies, (K Units), 2017-2022
Table 6. Global Nuclear Medicine & Radiopharmaceuticals Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Nuclear Medicine & Radiopharmaceuticals Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Nuclear Medicine & Radiopharmaceuticals Product Type
Table 9. List of Global Tier 1 Nuclear Medicine & Radiopharmaceuticals Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Nuclear Medicine & Radiopharmaceuticals Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type - Global Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Nuclear Medicine & Radiopharmaceuticals Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Nuclear Medicine & Radiopharmaceuticals Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Nuclear Medicine & Radiopharmaceuticals Sales (K Units), 2017-2022
Table 15. By Type - Global Nuclear Medicine & Radiopharmaceuticals Sales (K Units), 2023-2028
Table 16. By Application - Global Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Nuclear Medicine & Radiopharmaceuticals Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Nuclear Medicine & Radiopharmaceuticals Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Nuclear Medicine & Radiopharmaceuticals Sales (K Units), 2017-2022
Table 20. By Application - Global Nuclear Medicine & Radiopharmaceuticals Sales (K Units), 2023-2028
Table 21. By Region - Global Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Nuclear Medicine & Radiopharmaceuticals Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Nuclear Medicine & Radiopharmaceuticals Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Nuclear Medicine & Radiopharmaceuticals Sales (K Units), 2017-2022
Table 25. By Region - Global Nuclear Medicine & Radiopharmaceuticals Sales (K Units), 2023-2028
Table 26. By Country - North America Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Nuclear Medicine & Radiopharmaceuticals Sales, (K Units), 2017-2022
Table 29. By Country - North America Nuclear Medicine & Radiopharmaceuticals Sales, (K Units), 2023-2028
Table 30. By Country - Europe Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Nuclear Medicine & Radiopharmaceuticals Sales, (K Units), 2017-2022
Table 33. By Country - Europe Nuclear Medicine & Radiopharmaceuticals Sales, (K Units), 2023-2028
Table 34. By Region - Asia Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Nuclear Medicine & Radiopharmaceuticals Sales, (K Units), 2017-2022
Table 37. By Region - Asia Nuclear Medicine & Radiopharmaceuticals Sales, (K Units), 2023-2028
Table 38. By Country - South America Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Nuclear Medicine & Radiopharmaceuticals Sales, (K Units), 2017-2022
Table 41. By Country - South America Nuclear Medicine & Radiopharmaceuticals Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales, (K Units), 2023-2028
Table 46. China Isotope & Radiation Corporate Summary
Table 47. China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Product Offerings
Table 48. China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Dongcheng Corporate Summary
Table 50. Dongcheng Nuclear Medicine & Radiopharmaceuticals Product Offerings
Table 51. Dongcheng Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Jaco Corporate Summary
Table 53. Jaco Nuclear Medicine & Radiopharmaceuticals Product Offerings
Table 54. Jaco Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Ciaeriar Corporate Summary
Table 56. Ciaeriar Nuclear Medicine & Radiopharmaceuticals Product Offerings
Table 57. Ciaeriar Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Advanced Molecular-imaging Solution Corporate Summary
Table 59. Advanced Molecular-imaging Solution Nuclear Medicine & Radiopharmaceuticals Product Offerings
Table 60. Advanced Molecular-imaging Solution Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. Shanghai Atom Kexing Corporate Summary
Table 62. Shanghai Atom Kexing Nuclear Medicine & Radiopharmaceuticals Product Offerings
Table 63. Shanghai Atom Kexing Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. Nuclear Medicine & Radiopharmaceuticals Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 65. Global Nuclear Medicine & Radiopharmaceuticals Capacity Market Share of Key Manufacturers, 2020-2022
Table 66. Global Nuclear Medicine & Radiopharmaceuticals Production by Region, 2017-2022 (K Units)
Table 67. Global Nuclear Medicine & Radiopharmaceuticals Production by Region, 2023-2028 (K Units)
Table 68. Nuclear Medicine & Radiopharmaceuticals Market Opportunities & Trends in Global Market
Table 69. Nuclear Medicine & Radiopharmaceuticals Market Drivers in Global Market
Table 70. Nuclear Medicine & Radiopharmaceuticals Market Restraints in Global Market
Table 71. Nuclear Medicine & Radiopharmaceuticals Raw Materials
Table 72. Nuclear Medicine & Radiopharmaceuticals Raw Materials Suppliers in Global Market
Table 73. Typical Nuclear Medicine & Radiopharmaceuticals Downstream
Table 74. Nuclear Medicine & Radiopharmaceuticals Downstream Clients in Global Market
Table 75. Nuclear Medicine & Radiopharmaceuticals Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Nuclear Medicine & Radiopharmaceuticals Segment by Type
Figure 2. Nuclear Medicine & Radiopharmaceuticals Segment by Application
Figure 3. Global Nuclear Medicine & Radiopharmaceuticals Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Nuclear Medicine & Radiopharmaceuticals Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Nuclear Medicine & Radiopharmaceuticals Revenue, 2017-2028 (US$, Mn)
Figure 7. Nuclear Medicine & Radiopharmaceuticals Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Nuclear Medicine & Radiopharmaceuticals Revenue in 2021
Figure 9. By Type - Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share, 2017-2028
Figure 10. By Type - Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share, 2017-2028
Figure 11. By Type - Global Nuclear Medicine & Radiopharmaceuticals Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share, 2017-2028
Figure 13. By Application - Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share, 2017-2028
Figure 14. By Application - Global Nuclear Medicine & Radiopharmaceuticals Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share, 2017-2028
Figure 16. By Region - Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share, 2017-2028
Figure 17. By Country - North America Nuclear Medicine & Radiopharmaceuticals Revenue Market Share, 2017-2028
Figure 18. By Country - North America Nuclear Medicine & Radiopharmaceuticals Sales Market Share, 2017-2028
Figure 19. US Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Nuclear Medicine & Radiopharmaceuticals Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Nuclear Medicine & Radiopharmaceuticals Sales Market Share, 2017-2028
Figure 24. Germany Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 25. France Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Nuclear Medicine & Radiopharmaceuticals Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Nuclear Medicine & Radiopharmaceuticals Sales Market Share, 2017-2028
Figure 33. China Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 37. India Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Nuclear Medicine & Radiopharmaceuticals Revenue Market Share, 2017-2028
Figure 39. By Country - South America Nuclear Medicine & Radiopharmaceuticals Sales Market Share, 2017-2028
Figure 40. Brazil Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales Market Share, 2017-2028
Figure 44. Turkey Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Nuclear Medicine & Radiopharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 48. Global Nuclear Medicine & Radiopharmaceuticals Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Nuclear Medicine & Radiopharmaceuticals by Region, 2020 VS 2027
Figure 50. Nuclear Medicine & Radiopharmaceuticals Industry Value Chain
Figure 51. Marketing Channels
Global Antioxidant Vitamins Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 100
The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
Global Clavulanate Potassium Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 86
The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030.
North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
Global Amoxicillin Sodium Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 84
The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030.
North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
Global Melatonin Supplements Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 106
The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 93
The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
Global Sleeping Pills Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 94
The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
Global Zinc Oral Drops Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 85
The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
Global Zinc Drops Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 85
The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
Global Anti-Infectives Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 78
The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
